These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26407166)

  • 1. Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.
    Glenn JD; Smith MD; Kirby LA; Baxi EG; Whartenby KA
    PLoS One; 2015; 10(9):e0139008. PubMed ID: 26407166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model.
    Le Blon D; Guglielmetti C; Hoornaert C; Quarta A; Daans J; Dooley D; Lemmens E; Praet J; De Vocht N; Reekmans K; Santermans E; Hens N; Goossens H; Verhoye M; Van der Linden A; Berneman Z; Hendrix S; Ponsaerts P
    J Neuroinflammation; 2016 Nov; 13(1):288. PubMed ID: 27829467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
    Salinas Tejedor L; Berner G; Jacobsen K; Gudi V; Jungwirth N; Hansmann F; Gingele S; Prajeeth CK; Baumgärtner W; Hoffmann A; Skripuletz T; Stangel M
    Brain Behav Immun; 2015 Nov; 50():155-165. PubMed ID: 26140734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
    Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W
    Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination.
    El-Akabawy G; Rashed LA
    Ann Anat; 2015 Mar; 198():11-20. PubMed ID: 25660362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose-derived mesenchymal stem cells ameliorates experimental autoimmune encephalomyelitis via modulation of Th1/Th17 and expansion of Th2/Treg responses.
    Zargarani S; Tavaf MJ; Soltanmohammadi A; Yazdanpanah E; Baharlou R; Yousefi B; Sadighimoghaddam B; Esmaeili SA; Haghmorad D
    Cell Biol Int; 2024 Aug; 48(8):1124-1137. PubMed ID: 38741520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model.
    Tahmasebi F; Pasbakhsh P; Barati S; Madadi S; Kashani IR
    J Cell Physiol; 2021 May; 236(5):3552-3564. PubMed ID: 32996165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
    Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
    Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
    Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
    Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
    Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
    Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
    Vaitaitis GM; Yussman MG; Waid DM; Wagner DH
    PLoS One; 2017; 12(2):e0172037. PubMed ID: 28192476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.
    Nessler J; Bénardais K; Gudi V; Hoffmann A; Salinas Tejedor L; Janßen S; Prajeeth CK; Baumgärtner W; Kavelaars A; Heijnen CJ; van Velthoven C; Hansmann F; Skripuletz T; Stangel M
    PLoS One; 2013; 8(7):e69795. PubMed ID: 23922802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis.
    Shimojima C; Takeuchi H; Jin S; Parajuli B; Hattori H; Suzumura A; Hibi H; Ueda M; Yamamoto A
    J Immunol; 2016 May; 196(10):4164-71. PubMed ID: 27053763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
    Cobo M; Anderson P; Benabdellah K; Toscano MG; Muñoz P; García-Pérez A; Gutierrez I; Delgado M; Martin F
    Cell Transplant; 2013; 22(5):839-54. PubMed ID: 23031550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Bone Marrow Mesenchymal Stem Cells on Myelin Repair and Emotional Changes of a Cuprizone-Induced Demyelination Model.
    Lei C; Chen H; Chen K
    J Integr Neurosci; 2023 Feb; 22(2):40. PubMed ID: 36992584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.
    Bravo B; Gallego MI; Flores AI; Bornstein R; Puente-Bedia A; Hernández J; de la Torre P; García-Zaragoza E; Perez-Tavarez R; Grande J; Ballester A; Ballester S
    Stem Cell Res Ther; 2016 Mar; 7():43. PubMed ID: 26987803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.